Ginkgo Bioworks Holdings, Inc. ( DNA) - Key Metrics
DNA Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.32 | -$0.75 | -$0.75 | -$0.79 |
| 2026Q1 | $0.33 | -$1.39 | -$0.78 | -$0.81 |
| 2025Q4 | $0.60 | -$1.46 | -$0.86 | -$1.14 |
| 2025Q3 | $0.70 | -$1.45 | -$0.57 | -$0.57 |
| 2025Q2 | $0.90 | -$1.10 | -$0.73 | -$0.73 |
DNA Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.30 |
| 2026Q1 | 0% | -1.10 |
| 2025Q4 | 0% | -1.45 |
| 2025Q3 | 0% | -2.51 |
| 2025Q2 | 0% | -2.56 |
DNA
Price: $6.79
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.33 USD
Exchange: NYQ
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 21.0 million
Market Capitalization: 505.7 million